Comparative study of bioartificial liver support and plasma exchange for treatment of pigs with fulminant hepatic failure

Artificial Organs

Volumn 24, Issue 4, 2000, Pages 265-270

  Kamohara, Yukio ^a   Fujioka, Hikaru ^a   Eguchi, Susumu ^a   Kawashita, Yujo ^a   Furui, Junichiro ^a   Kanematsu, Takashi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bioartificial liver support; Fulminant hepatic failure; Porcine hepatocyte

Indexed keywords

MAMMALS; PATIENT TREATMENT;

BENEFICIAL EFFECTS; BIOARTIFICIAL LIVER; BIOARTIFICIAL LIVER SUPPORT; CLINICAL TRIAL; COMPARATIVES STUDIES; EXPERIMENTAL TRIALS; FULMINANT HEPATIC FAILURES; HEPATOCYTES; PLASMA EXCHANGES; PORCINE HEPATOCYTE;

ARTIFICIAL ORGANS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL LIVER; BRAIN PERFUSION; CONTROLLED STUDY; FEMALE; LIVER CELL; LIVER FAILURE; LIVER ISCHEMIA; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; SURVIVAL TIME; SWINE;

EID: 0034021396     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2000.06500.x     Document Type: Article

References (24)

1. 1. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: Summary of a workshop. Hepatology 1995;21:240-52.
2. 2. Denis J, Opolon P, Nusinovici V, Granger A, Darnis F. Treatment of encephalopathy during fulminant hepatic failure by hemodialysis with high permeability membrane. Gut 1978;19: 787-93.
3. 3. Hughes RD, Williams R. Use of sorbent columns and hemofiltration in fulminant hepatic failure. Blood Purif 1993;11: 163-9.
4. 4. Matsubara S. Combination of plasma exchange and continuous hemofiltration as temporary metabolic support for patients with acute liver failure. Artif Organs 1994;18:363-6.
5. 5. O'Grady JG, Gimson AE, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988;94:1186-92.
6. 6. Sorrentino F. Prime ricerche per la realizzatione di un fegato artificiale. Chir Pathol Sper 1956;4:1401-14.
7. 7. Abouna GM, Cook JS, Fisher LM, Still WJ, Costa G, Hume DM. Treatment of acute hepatic coma by baboon and human liver perfusions. Surgery 1972;71:537-46.
8. 8. Fujioka H, Cramer DV, Yasunaga C, Tuso PJ, Wu GD, Middleton Y, Moscioni AD, Rozga J, Demetriou AA, Makowka L. Differential patterns of reaction of human natural antibodies to pig hepatocytes and vascular endothelium. Liver Transpl Surg 1995;1:85-93.
9. 9. Demetriou AA, Whiting J, Levenson SM, Chowdhury NR, Feldman D, Moscioni AD, Chowdhury JR. New method of hepatocyte transplantation and extracorporeal liver support. Ann Surg 1986;204:259-71.
10. 10. Nyberg Shatford RA, Peshwa MV, White JM, Cerra FB, Hu WS. Evaluation of the hepatocyte entrapment hollow-fiber bioreactor, a potential use in bioartificial liver. Biotechnol Bioeng 1989;41:194-203.
11. 11. Joly A, Desjardins JF, Fremond B, Desille M, Campion JP, Malledant Y. Survival proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: A step toward a reliable bioartificial liver. Transplantation 1997;63: 795-803.
12. 12. Gerlach J, Schnoy N, Smith MD, Neuhaus P. Hepatocyte culture between woven capillary networks. A microscopy study. Artif Organs 1997;18:226-30.
13. 13. Rozga J, Podesta L, LePage E, Huffman A, Morsiani E, Sher L, Woolf GM, Makowka L, Cramer DV, Demetriou AA. A bioartificial liver to treat severe acute liver failure. Ann Surg 1994;219:538-46.
14. 14. Kamohara Y, Rozga J, Demetriou AA. Artificial liver: Review and Cedars-Sinai experience. J Hepatobiliary Pancreat Surg 1998;5:273-85.
15. 15. Berry MN, Friend DS. High-yield preparation of isolated rat liver parenchymal cells: A biochemical and structural study. J Cell Biol 1969;43:506-20.
16. 16. Mazziotti A, Bernardi M, Antonini L, Dioguardi FS, Bellusci R, Papa V, Tacconi C, Gasbarrini, Cavallari A, Possati L. Plasma amino acid patterns in experimental acute hepatic failure: Comparison between hepatectomy and liver devascularization in pigs. Surgery 1981;90:527-34.
17. 17. Lepore MJ, Stutman LJ, Bonanno CA, Conklin EF, Robilotti JG Jr, McKenna PJ. Plasmapheresis with plasma exchange in hepatic coma. Arch Intern Med 1972;129:900-7.
18. 18. Watanabe A, Hayashi S, Higashi T, Obata T, Sakata T, Takei N, Shiota T, Nagashima H. Characteristic change in serum amino acid levels in different types of hepatic encephalopathy. Gastroenterol Jpn 1982;17:218-23.
19. 19. Kato M, Hughes RD, Keays RT, Williams R. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology 1992;5:1060-6.
20. 20. Blei AT, Olafson S, Therrien G, Butterworth RF. Ammonia-induced brain edema and intracranial hypertension in rats after portocaval anastomosis. Hepatology 1994;19:1437-44.
21. 21. Rozga J, Podesta L, LePage E, Morsiani E, Sher L, Woolf GM, Hoffman A, Makowka L, Demetriou AA. Control of cerebral edema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 1993;342:898-9.
22. 22. Eguchi S, Sugiyama N, Kawazoe Y, Kawashita Y, Fujioka H, Furui J, Kanematsu T. Total blood exchange suppresses the early stage of liver regeneration following partial hepatectomy in rats. Artif Organs 1998;22:847-53.
23. 23. Kamohara Y, Lilja H, Neuman T, Demetriou AA, Rozga J. Activities of proliferation associated and liver-enriched transcription factors in rats with surgically induced liver failure. Surg Forum 1998;XLIX:157-8.
24. 24. Suh KS, Lilja H, Kamohara Y, Neuman T, Demetriou AA, Rozga J. Bioartificial liver treatments in rats with fulminant hepatic failure: Effect on DNA binding activity of liver-enriched and growth-associated transcription factors. J Surg Res 1999;85:243-50.